Republican Sen. David McCormick defended Donald Trump’s latest controversial moves in a rare interview, including the ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.

Donald Trump confused his recent dementia screening for a "very hard" IQ test. The president bragged about the results of his ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Please provide your email address to receive an email when new articles are posted on . Testing revealed significant cognitive differences between patients with Alzheimer’s or dementia and healthy ...

The FDA has approved the Elecsys pTau181 test to assist in the initial assessment for Alzheimer's disease and other causes of ...

Donald Trump has appeared to confuse a medical cognitive screening with an IQ test as he bragged about his results. ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...

Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...